Welcome

to Galapagos


Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action.

Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

Want to know more about unmet needs in RA, JAK-STAT, treatment guidelines, or clinical outcomes?
What causes JAK-STAT signalling dysregulation and inflammatory response?

Therapy Areas

Product Information

Please visit your country website for more detailed product information

Clinical Trials

Register now for access to information on ongoing clinical trials

Events

  • {{m.monthYear}}
No events found.
{{calendar.eventCategory}}

{{ calendar.eventHourMin}} ({{ calendar.timezone}})

{{calendar.eventName}}

{{calendar.eventDescription}}

  • {{page}}
No events found.
{{calendar.eventCategory}}

{{ calendar.eventHourMin}} ({{ calendar.timezone}})

{{calendar.eventName}}

{{calendar.eventDescription}}

  • {{page}}

About us

Our Research

Galapagos’ core research areas are inflammatory, fibrotic, and kidney diseases, where our clinical activity is focused across several indications.